GGrantIndex
← Leaderboards

Marc C. Levesque

Duke University

$4,161,424
Attributed
$6,196,328
Total exposure
7
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY200513
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13

Funding mix

By agency

NIH$6,196,328 · 7

By mechanism

RC2$2,872,161 · 1
R01$2,586,327 · 2
R21$421,589 · 1
R03$297,000 · 2
M01$19,251 · 1

Top collaborators

Most similar at Duke University

Same institution · by research overlap

Others in their field

Top investigators on “Rheumatoid Arthritis

Research focus

Rheumatoid ArthritisBloodFundingLaboratoriesBiologicalEffectivenessSpecimenBaseMediatingLeadPublic Health RelevanceImmuneNitric OxideAutoimmune DiseasesPeripheral BloodMorbidity - Disease RateAdultCessation Of LifeMortality Vital StatisticsB-LymphocytesImmunoglobulinsFlow CytometryCytokineGenes

Grant awards (19)

Mechanisms of Response and Relapse in Rituximab-treated Myositis Patients$282,301
R01 · FY2013 · AR
Mechanisms of Response and Relapse in Rituximab-treated Myositis Patients$297,142
R01 · FY2012 · AR
Mechanisms of Response and Relapse in Rituximab-treated Myositis Patients$297,126
R01 · FY2011 · AR
Randomized observation study of biologic therapy for rheumatoid arthritis$1,366,857
RC2 · FY2010 · AR
Mechanisms of Response and Relapse in Rituximab-treated Myositis Patients$321,078
R01 · FY2010 · AR
Randomized observation study of biologic therapy for rheumatoid arthritis$164,718
RC2 · FY2010 · AR
Randomized observation study of biologic therapy for rheumatoid arthritis$1,340,586
RC2 · FY2009 · AR
Prevention of Chronic Lymphocytic Leukemia (CLL)$78,000
R03 · FY2008 · CA · contact PI
Human TNFa-Induced Pre-B Cell Bone Marrow Emigrants$227,214
R21 · FY2007 · AI · contact PI
Prevention of Chronic Lymphocytic Leukemia (CLL)$78,000
R03 · FY2007 · CA · contact PI
Nitric Oxide Metabolism in Statin-treated Pediatric SLE$303,424
R01 · FY2006 · AR · contact PI
Human TNFa-Induced Pre-B Cell Bone Marrow Emigrants$194,375
R21 · FY2006 · AI · contact PI
Nitric Oxide Metabolism in Statin-treated Pediatric SLE$356,165
R01 · FY2005 · AR
NITRIC OXIDE, LPS AND THE PATHOGENESIS OF ASTHMA$18,829
M01 · FY2005 · RR
Nitric Oxide Metabolism in Statin-treated Pediatric SLE$363,498
R01 · FY2004 · AR
Nitric Oxide, LPS and the Pathogenesis of Asthma$422
M01 · FY2004 · RR
Nitric Oxide Metabolism in Statin-treated Pediatric SLE$365,593
R01 · FY2003 · AR
HYALURONAN-MEDIATED NITRIC OXIDE PRODUCTION BY MACROPHAG$70,500
R03 · FY2001 · AR
HYALURONAN-MEDIATED NITRIC OXIDE PRODUCTION BY MACROPHAG$70,500
R03 · FY2000 · AR